Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Cancer Immunity|December 18, 2003
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2Claudia Wagner, Frank Neumann, Boris Kubuschok, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2012
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16Lisa M Pörtner, Kathrin Schönberg, Maryam Hejazi, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2009
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomasCarsten Zwick, Gerhard Held, Vera Hammermeister, et al.
Human Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.
Alzheimer'S Research & Therapy|October 20, 2023
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD miceDeebika Balu, Ana C Valencia-Olvera, Austin Nguyen, et al.
Blood|June 4, 2011
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial systemThomas Luft, Sascha Dietrich, Christine Falk, et al.
Vaccine|July 25, 2006
Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiaeAndreas Wadle, Gerhard Held, Frank Neumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancerBoris Kubuschok, Frank Neumann, Rainer Breit, et al.
Hematological Oncology|May 2, 2008
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf studyFrank Neumann, Judith Markett, Roland Fenk, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Cancer Immunity|December 18, 2003
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2Claudia Wagner, Frank Neumann, Boris Kubuschok, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2012
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16Lisa M Pörtner, Kathrin Schönberg, Maryam Hejazi, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2009
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomasCarsten Zwick, Gerhard Held, Vera Hammermeister, et al.
Human Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.
Alzheimer'S Research & Therapy|October 20, 2023
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD miceDeebika Balu, Ana C Valencia-Olvera, Austin Nguyen, et al.
Blood|June 4, 2011
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial systemThomas Luft, Sascha Dietrich, Christine Falk, et al.
Vaccine|July 25, 2006
Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiaeAndreas Wadle, Gerhard Held, Frank Neumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancerBoris Kubuschok, Frank Neumann, Rainer Breit, et al.
Hematological Oncology|May 2, 2008
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf studyFrank Neumann, Judith Markett, Roland Fenk, et al.
Pageof 12